“Yoga for Stress Relief’s” 90-day program helps to successfully prevent and relieve the accumulation of stress through the practice of yoga, the postures, breathing–and meditations–and provides an understanding of the causes and development of stress Targeted print ads .
A commercial grade recumbent exercise bike which surpasses the needs for many clinical and training applications yet is appropriate for the demanding home user. The precisely engineered e-sys is designed to bring the electronic and mechanical functions of the RX7 into perfect body function and ergonomic harmony. Our exclusive design gives you better biomechanics while working the lower body in a correct and balanced fashion. The quiet and smooth pedaling is a delight for every user- from beginner to the well conditioned athlete.
 pIn prior research, investigators from Translational Genomics Research Institute (TGen) and the University of Southern California’s Keck School of Medicine had found that genetic variations in the peroxisome proliferator-activated receptor-g (PPARG) gene were associated with the metabolism and biological effects of a class of insulin-sensitizing drugs called thiazolidinediones (TZDs). (TZDs are used to treat type 2 diabetes by directly and indirectly affecting adipose tissue and muscle to improve insulin sensitivity. Such TZD drugs as Actos can significantly lower the incidence of diabetes in people at risk, potentially preventing the disease.) While the researchers knew that the genetic variations in the PPARG gene contributed to the therapeutic response associated with TZD, the variations did not fully explain why up to 40 percent of patients fail to respond to the drug. This led them to believe that other factors may be involved./ppThe researchers set to work to identify other variants that may predict response to TZDs. Toward this end, they performed a genome-wide analysis of 115,352 single nucleotide polymorphisms, as well as systematically screened 28 key genes involved in TZD metabolism or PPARG-stimulated pathways. They found five critical markers that may predict response to TZD mono-therapy. /pp”We identified genetic variants that may predict how well someone will respond to the common anti-diabetes drug, Actos,” says Dr. DiStefano, Director of TGen’s Diabetes, Cardiovascular and Metabolic Diseases Division. “The implications of these findings include determining which patients will best respond to the drug for the prevention or treatment of diabetes.” The next step in the research process, says Dr. DiStefano, will be to characterize the functional effects of the polymorphisms and determine the effect of these variants in other patients./pp”This work may help treat the right people with the right drug, design better drugs that will effectively improve insulin sensitivity for more people, and possibly safeguard against adverse side reactions seen with some members of this drug class,” she explains. “Importantly, these findings will enable us to dissect the pharmacogenetics of TZD response, which will expand our understanding of the genetic determinants of insulin resistance and its treatment, provide critical baseline information for the development and implementation of genetic screening into the therapeutic decision making process, and lay the foundation for “individualized medicine” for patients with type 2 diabetes.”/ppNews Release: TGen researchers find genetic markers to help fight diabetes span style=”font-family: Arial; font-size: 11pt”a href=”http://www.tgen.org/”spanufont color=”#0000ff”a href=”http://www.tgen.org/news/index.cfm?newsid=1568″ target=”_blank”www.tgen.org/a/font/u/span/a /spanJune 15, 2009/pimg src=”http://feeds2.feedburner.com/~r/worldhealth_full/~4/utO9rbkzNo4″ height=”1″ width=”1″/
 pFive years ago, a critical discovery in the understanding of cellular aging was made by researchers from the University of North Carolina (UNC) at Chapel Hill Lineberger Comprehensive Cancer Center. Through their research, they learned that expression of a key tumor suppressor protein — p16INK4a – dramatically increases in most mammalian organs with the aging of cells and tissue. /ppNow, a new study conducted by the same team of researchers has shown that p16INK4a is also present in human blood and is strongly associated with aging and such behaviors as tobacco use and physical inactivity, both of which are known to accelerate the aging process. Moreover, the researchers have been able to develop a simple blood test capable of detecting p16INK4a, which is present in T-lymphocytes. Their research was based upon two key factors: blood taken from 170 healthy human volunteers and a questionnaire that the participants completed, providing information about past and current health status and behaviours. As the scientists discovered, the expression of p16INK4a increased exponentially with age, and that those increased levels were independently associated with tobacco use, physical inactivity and with biomarkers of human frailty. /pp”This is a major step toward a practical tool to clinically determine a person’s actual molecular age, as opposed to just their chronological age,” emphasizes UNC Lineberger member Norman Sharpless, M.D., the senior author of the study and associate professor of medicine and genetics at UNC’s School of Medicine. “We found a very weak correlation between the biomarker and obesity as measured by body mass index, despite other data suggesting that caloric restriction slows aging. The data suggest the possibility that reduced exercise may actually be worse with regard to molecular age than a higher BMI,” says Dr. Sharpless, who expressed surprise about the findings./pp”Although we don’t know whether this test is a good reflection of cellular age in all types of human tissues, we believe it is a first step toward a better understanding of issues like the suitability of organs for transplantation, how well patients are likely to recover after surgery or the future toxicity of chemotherapy for cancer patients,” he adds. Study findings are being published in the journal emAging Cell/em./pNews Release: Test detects molecular marker of aging in humans  span style=”font-family: Arial; color: black; font-size: 11pt”a href=”http://www.eurekalert.org/pub_releases/2009-06/uonc-tdm061509.php” target=”_blank”ufont color=”#0000ff”www.eurealert.org/font/u/a/spanspan style=”font-family: Arial; font-size: 11pt”font color=”#000000″June 16, 2009o:p/o:p/font/spanspan style=”font-family: Arial; font-size: 11pt”font color=”#000000″ o:p/o:p/font/spanpnbsp;/ppnbsp;/pimg src=”http://feeds2.feedburner.com/~r/worldhealth_full/~4/nmmalsHp1h0″ height=”1″ width=”1″/
Best selling author and fitness celebrity Bob Greene teams up with SPRI to bring you a strength-training program proven to help you lose weight and look great! Based on the philosophies and techniques presented in his book, Bob shows you how to maintain weight loss by building a stronger body.
“Stretching Basics” is a user-friendly guide to achieving a more supple and flexible physique using your own body as resistance. It provides an introductory guide for stretching and flexibility for sport, lifestyle, and injury prevention. With step-by-step illustrated instructions for more than 50 exercises, readers will be able to improve flexibility and range of motion, as well as reduce muscular tension throughout the whole body. Also included is a testing and stretching routine for reducing lower back tension, and exercises that can be done quickly and easily, virtually anywhere.
Mercola News